Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Capital Expenditures (2019 - 2025)

Outset Medical (OM) has disclosed Capital Expenditures for 7 consecutive years, with $223000.0 as the latest value for Q4 2025.

  • Quarterly Capital Expenditures rose 418.6% to $223000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $798000.0 through Dec 2025, down 12.5% year-over-year, with the annual reading at $798000.0 for FY2025, 12.5% down from the prior year.
  • Capital Expenditures for Q4 2025 was $223000.0 at Outset Medical, up from $160000.0 in the prior quarter.
  • The five-year high for Capital Expenditures was $7.8 million in Q4 2022, with the low at -$2.9 million in Q3 2022.
  • Average Capital Expenditures over 5 years is $515750.0, with a median of $265000.0 recorded in 2021.
  • The sharpest move saw Capital Expenditures plummeted 694.5% in 2022, then surged 543.64% in 2024.
  • Over 5 years, Capital Expenditures stood at -$2.1 million in 2021, then soared by 463.72% to $7.8 million in 2022, then crashed by 128.68% to -$2.2 million in 2023, then skyrocketed by 101.93% to $43000.0 in 2024, then surged by 418.6% to $223000.0 in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $223000.0, $160000.0, and $292000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.